SI

Silo Pharma, Inc.

  • CIK: 0001514183
  • EIN: 46-2137136
  • Business address: 560 SYLVAN AVE, SUITE 3160, ENGLEWOOD CLIFFS, New Jersey, 07632

Information

  • Mailing address
    560 SYLVAN AVE, SUITE 3160, ENGLEWOOD CLIFFS, Delaware, 07632
  • Phone
    (718) 400-9031
  • State location
    New Jersey
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2300 - (CF Office: Office of Manufacturing) APPAREL & OTHER FINISHD PRODS OF FABRICS & SIMILAR MATL
  • Filings
    N/A

About Silo Pharma, Inc.

Silo Pharma, Inc. (CIK: 0001514183) is an American company incorporated in the state of New Jersey. Head office is located at 560 SYLVAN AVE, SUITE 3160, ENGLEWOOD CLIFFS, New Jersey, 07632. Work in the industry 2300 - (CF Office: Office of Manufacturing) APPAREL & OTHER FINISHD PRODS OF FABRICS & SIMILAR MATL. Silo Pharma, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

  • Uppercut Brands, Inc. from 2019-13-Aug to 2020-14-Aug
  • Point Capital, Inc. from 2013-30-Jan to 2019-14-May
  • Gold Swap Inc from 2011-30-Mar to 2013-07-Jan

Ownership

Owner Filings Transaction Date Type of Owner
Ryweck Daniel E. 0001652799 Sep-27-2022 officer: Chief Financial Officer
Pavell Jeff 0001840601 Sep-27-2022 director
Munoz Kevin 0001847763 Oct-01-2020 director
Linsley Wayne 0001809972 Jan-16-2020 director
WASSERMAN ADAM C 0001171265 Jul-23-2015 officer: Chief Financial Officer
SCHILLER LEONARD M 0001201808 Jul-30-2014 director
Stone, Joel Alan 0001615103 Jul-30-2014 director
Weisblum Eric 0001569077 Jan-28-2014 director, officer: President and CCO
Parker Walter Van Eps 0001293959 Jan-28-2013 director
Brand Richard 0001372260 Jan-28-2013 director, officer: Chairman and CEO
WHALEHAVEN CAPITAL FUND LTD 0001326903 Nov-29-2012 10 percent owner
MATS VADIM 0001546594 Jul-20-2011 officer: VP of Business Development
Ptalis Donald 0001565771 Jul-20-2011 director, officer: CFO
Schlossberg Melvin 0001566261 Jul-20-2011 director, 10 percent owner, officer: PRESIDENT, CEO & SECRETARY

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Silo Pharma, Inc.

Filings Format Description Filed/Effective File/Film Number
8-K Document

Current report filing

Acc-no: 0001213900-26-019384 (34 Act) Size: KB		 Feb-23-2026

001-41512

26666163
SCHEDULE 13G/A Document Acc-no: 0001193125-26-053479 (34 Act) Size: KB Feb-17-2026

005-87110

26637675
SCHEDULE 13G/A Document Acc-no: 0001213900-26-016528 (34 Act) Size: KB Feb-13-2026

005-87110

26634068
SCHEDULE 13G/A Document Acc-no: 0001213900-26-016071 (34 Act) Size: KB Feb-13-2026

005-87110

26630473
8-K Document

Current report filing

Acc-no: 0001213900-25-125838 (34 Act) Size: KB		 Dec-29-2025

001-41512

251603772
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001213900-25-122429 ( Act) Size: 0 KB		 Dec-16-2025

EFFECT Document Acc-no: 9999999995-25-003402 (33 Act) Size: KB Nov-26-2025

333-291129

251532232
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0001213900-25-115503 (33 Act) Size: KB		 Nov-26-2025

333-291129

251530455
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001213900-25-113743 ( Act) Size: 0 KB		 Nov-21-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001213900-25-113104 ( Act) Size: 0 KB		 Nov-20-2025

SCHEDULE 13G Document Acc-no: 0001193125-25-282676 (34 Act) Size: KB Nov-14-2025

005-87110

251484981
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001213900-25-110006 (34 Act) Size: KB		 Nov-13-2025

001-41512

251478782
SCHEDULE 13G/A Document Acc-no: 0001213900-25-107728 (34 Act) Size: KB Nov-07-2025

005-87110

251463743
S-1 Document

General form of registration statement for all companies including face-amount certificate companies

Acc-no: 0001213900-25-103188 (33 Act) Size: KB		 Oct-29-2025

333-291129

251426296
8-K Document

Current report filing

Acc-no: 0001213900-25-102222 (34 Act) Size: KB		 Oct-24-2025

001-41512

251416637
SCHEDULE 13G Document Acc-no: 0001213900-25-096008 (34 Act) Size: KB Oct-03-2025

005-87110

251373323
8-K Document

Current report filing

Acc-no: 0001213900-25-094711 (34 Act) Size: KB		 Oct-01-2025

001-41512

251365029
424B5 Document

Prospectus filed pursuant to Rule 424(b)(5)

Acc-no: 0001213900-25-094384 (33 Act) Size: KB		 Oct-01-2025

333-276658

251362672
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001213900-25-085128 (34 Act) Size: KB		 Sep-05-2025

001-41512

251297445
ARS Document

Annual report to security holders

Acc-no: 0001213900-25-085125 (34 Act) Size: KB		 Sep-05-2025

001-41512

251297429

Recent 20 filings. View all Silo Pharma, Inc. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Frequently Asked Questions

Tags:

  • Silo Pharma, Inc. overview
  • Silo Pharma, Inc. job
  • Silo Pharma, Inc. stock
  • Silo Pharma, Inc. ownership
  • Silo Pharma, Inc. CEO
  • Silo Pharma, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Riverstone Ltd
Update: Dec 30, 2025
BrilliA Inc
Update: Sep 13, 2024
Amer Sports, Inc.
Update: Jan 05, 2024
COR3&Co. (Holdings) Ltd
Update: Nov 21, 2023
Neo-Concept International Group Holdings Ltd
Update: Nov 02, 2023
Majestic Ideal Holdings Ltd
Update: Apr 29, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1936 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 2021 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2993 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2718 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4488 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3325 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3071 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3472 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4229 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by